PDCD1 and neoplasm: The EMT-6 is considered an anti-PD-1 resistant tumor, due to an immune excluded phenotype, macrophage-derived suppressive infiltration, immunosuppressive cytokine such as TGF-β, and epithelial-to-mesenchymal transition (EMT) [21–23].